Advertisement
Screener

MaxCyte, Inc. (MXCT) ROE

MaxCyte, Inc. (MXCT) ROE

  • 2026-06-30: ROE -22.45%.
  • 2026-03-31: ROE -23.30%.
  • 2025-12-31: ROE -26.02%.
  • 2025-09-30: ROE -25.31%.

Complete source-backed roe history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-30-22.45%
2026-03-31-23.30%
2025-12-31-26.02%
2025-09-30-25.31%
2025-06-30-23.47%
2025-03-31-20.96%
2024-12-31-19.91%
2024-09-30-16.75%
2024-06-30-16.01%
2024-03-31-16.15%
2023-12-31-16.33%
2023-09-30-16.05%
2023-06-30-13.54%
2023-03-31-12.26%
2022-12-31-9.28%
2022-09-30-9.29%
2022-06-30-7.73%
2022-03-31-6.12%
2021-12-31-7.26%
2021-09-30-6.38%
2021-06-30-21.92%
2021-03-31-19.51%
2020-12-31-35.56%

Annual ROE

DateROE
2025-12-31-26.02%
2024-12-31-19.91%
2023-12-31-16.33%
2022-12-31-9.28%
2021-12-31-7.26%
2020-12-31-35.56%
2019-12-31-94.80%

Similar stocks

Stock NameCountryMarket CapPE Ratio
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71
NRC HEALTH (NRC)United States$0.450B42.50
OmniAb, Inc. (OABI)United States$0.698B-8.05
Absci Corp (ABSI)United States$1.775B-14.92
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)United States$14.060B-43.97
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14